Skip to content

Clinical trials

Recruiting Neurobehavioral Manifestations trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurobehavioral Manifestations Status: Recruiting Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20171
20181
20191
20211
20221
20233
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Texas Health Science Center at San Antonio2
VA Office of Research and Development2
American Federation of Medical Synergetics1
Beth Israel Deaconess Medical Center1
Connecta Therapeutics, S.L.1
Emory University1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
International Rett Syndrome Foundation1
Karolinska University Hospital1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurobehavioral Manifestations20
Nervous System Diseases4
Neurodevelopmental Disorders3
Neurologic Manifestations3
Autism Spectrum Disorder2
Autistic Disorder2
Brain Concussion2
Brain Injuries, Traumatic2
Child Development Disorders, Pervasive2
Cognitive Dysfunction2

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.